Valneva SE (VALN)
8.70
-0.18
(-2.03%)
USD |
NASDAQ |
May 20, 10:18
Valneva Price to Book Value: 2.962 for May 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.023 |
| May 16, 2024 | 3.001 |
| May 15, 2024 | 3.013 |
| May 14, 2024 | 2.727 |
| May 13, 2024 | 2.591 |
| May 10, 2024 | 2.526 |
| May 09, 2024 | 2.424 |
| May 08, 2024 | 2.465 |
| May 07, 2024 | 2.554 |
| May 06, 2024 | 2.554 |
| May 03, 2024 | 2.625 |
| May 02, 2024 | 2.528 |
| May 01, 2024 | 2.577 |
| April 30, 2024 | 2.537 |
| April 29, 2024 | 2.618 |
| April 26, 2024 | 2.601 |
| April 25, 2024 | 2.571 |
| April 24, 2024 | 2.639 |
| April 23, 2024 | 2.636 |
| April 22, 2024 | 2.697 |
| April 19, 2024 | 2.582 |
| April 18, 2024 | 2.768 |
| April 17, 2024 | 2.639 |
| April 16, 2024 | 2.724 |
| April 15, 2024 | 2.894 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.898 |
| April 11, 2024 | 3.027 |
| April 10, 2024 | 2.881 |
| April 09, 2024 | 2.738 |
| April 08, 2024 | 2.932 |
| April 05, 2024 | 2.806 |
| April 04, 2024 | 2.770 |
| April 03, 2024 | 2.812 |
| April 02, 2024 | 2.628 |
| April 01, 2024 | 2.615 |
| March 31, 2024 | |
| March 28, 2024 | 3.877 |
| March 27, 2024 | 3.894 |
| March 26, 2024 | 3.828 |
| March 25, 2024 | 3.821 |
| March 22, 2024 | 3.764 |
| March 21, 2024 | 3.627 |
| March 20, 2024 | 3.476 |
| March 19, 2024 | 3.877 |
| March 18, 2024 | 3.781 |
| March 15, 2024 | 3.774 |
| March 14, 2024 | 3.635 |
| March 13, 2024 | 3.657 |
| March 12, 2024 | 3.610 |
| March 11, 2024 | 3.612 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.424
Minimum
May 09 2024
38.49
Maximum
Nov 29 2021
9.385
Average
5.716
Median
Nov 07 2022
Price to Book Value Benchmarks
| DBV Technologies SA | 1.137 |
| Cellectis SA | 2.515 |
| PHAXIAM Therapeutics SA (DELISTED) | 0.4731 |
| Genfit SA | 2.682 |
| Innate Pharma SA | 4.115 |
Price to Book Value Related Metrics
| PS Ratio | 3.660 |
| Price | 8.70 |
| Earnings Yield | -4.72% |
| Market Cap | 605.31M |